Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chun-Han Cheng

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|November 26, 2018
Long-term histological change in chronic hepatitis C patients who had received peginterferon plus ribavirin therapy with sustained virological responseChia-Ying Chu, Chun-Han Cheng, Huan-Lin Chen, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|October 27, 2018
Evaluation of cost-effectiveness of peginterferon plus ribavirin for chronic hepatitis C treatment and direct-acting antiviral agents among HIV-infected patients in the prison and community settingsCheng-Pin Chen, Chien-Yu Cheng, Huachun Zou, et al.
Plos One|March 29, 2018
Is endotracheal intubation a non-beneficial treatment in patients with respiratory failure due to paraquat poisoning?Meng-Ruey Wu, Chia-Ying Hsiao, Chun-Han Cheng, et al.
The Kaohsiung Journal of Medical Sciences|October 1, 2017
High frequencies of a favorable IL-28B rs8099917 polymorphism and the clinical implications in patients with HCV in one multiracial area of TaiwanChun-Han Cheng, Ching-Chung Lin, Huan-Lin Chen, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|December 14, 2019
Subgroup analysis of the predictive ability of aspartate aminotransferase to platelet ratio index (APRI) and fibrosis-4 (FIB-4) for assessing hepatic fibrosis among patients with chronic hepatitis CChun-Han Cheng, Chia-Ying Chu, Huan-Lin Chen, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|December 19, 2020
Direct-acting antiviral therapy of chronic hepatitis C improves liver fibrosis, assessed by histological examination and laboratory markersChun-Han Cheng, Chia-Ying Chu, Huan-Lin Chen, et al.
Plos One|August 3, 2017
Application of chronic liver failure-sequential organ failure assessment score for the predication of mortality after esophageal variceal hemorrhage post endoscopic ligationMing-Wun Wong, Ming-Jen Chen, Huan-Lin Chen, et al.
The Journal of Infectious Diseases|April 9, 2019
An Open-Label, Randomized, Active-Controlled Trial of 8 Versus 12 Weeks of Elbasvir/Grazoprevir for Treatment-Naive Patients With Chronic Hepatitis C Genotype 1b Infection and Mild Fibrosis (EGALITE Study): Impact of Baseline Viral Loads and NS5A Resistance-Associated SubstitutionsChung-Feng Huang, Chao-Hung Hung, Pin-Nan Cheng, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|November 26, 2018
Long-term histological change in chronic hepatitis C patients who had received peginterferon plus ribavirin therapy with sustained virological responseChia-Ying Chu, Chun-Han Cheng, Huan-Lin Chen, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|October 27, 2018
Evaluation of cost-effectiveness of peginterferon plus ribavirin for chronic hepatitis C treatment and direct-acting antiviral agents among HIV-infected patients in the prison and community settingsCheng-Pin Chen, Chien-Yu Cheng, Huachun Zou, et al.
Plos One|March 29, 2018
Is endotracheal intubation a non-beneficial treatment in patients with respiratory failure due to paraquat poisoning?Meng-Ruey Wu, Chia-Ying Hsiao, Chun-Han Cheng, et al.
The Kaohsiung Journal of Medical Sciences|October 1, 2017
High frequencies of a favorable IL-28B rs8099917 polymorphism and the clinical implications in patients with HCV in one multiracial area of TaiwanChun-Han Cheng, Ching-Chung Lin, Huan-Lin Chen, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|December 14, 2019
Subgroup analysis of the predictive ability of aspartate aminotransferase to platelet ratio index (APRI) and fibrosis-4 (FIB-4) for assessing hepatic fibrosis among patients with chronic hepatitis CChun-Han Cheng, Chia-Ying Chu, Huan-Lin Chen, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|December 19, 2020
Direct-acting antiviral therapy of chronic hepatitis C improves liver fibrosis, assessed by histological examination and laboratory markersChun-Han Cheng, Chia-Ying Chu, Huan-Lin Chen, et al.
Plos One|August 3, 2017
Application of chronic liver failure-sequential organ failure assessment score for the predication of mortality after esophageal variceal hemorrhage post endoscopic ligationMing-Wun Wong, Ming-Jen Chen, Huan-Lin Chen, et al.
The Journal of Infectious Diseases|April 9, 2019
An Open-Label, Randomized, Active-Controlled Trial of 8 Versus 12 Weeks of Elbasvir/Grazoprevir for Treatment-Naive Patients With Chronic Hepatitis C Genotype 1b Infection and Mild Fibrosis (EGALITE Study): Impact of Baseline Viral Loads and NS5A Resistance-Associated SubstitutionsChung-Feng Huang, Chao-Hung Hung, Pin-Nan Cheng, et al.
Pageof 4